- Home
- PODC vs IOBT Comparison
PODC vs IOBT Comparison
Compare PODC & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.70
Company Overview
Basic Information| Metric | PODC | IOBT |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.5M | 57.2M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | PODC | IOBT |
|---|---|---|
| Price | $2.16 | $0.70 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 76.4K | ★ 919.6K |
| Earning Date | 11-11-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $56,957,000.00 | N/A |
| Revenue This Year | $17.39 | N/A |
| Revenue Next Year | $19.94 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 20.01 | N/A |
| 52 Week Low | $1.28 | $0.32 |
| 52 Week High | $2.94 | $2.79 |
Technical Indicators
Market Signals| Indicator | PODC | IOBT |
|---|---|---|
| Relative Strength Index (RSI) | 47.01 | 45.16 |
| Support Level | $1.91 | $0.59 |
| Resistance Level | $2.40 | $0.76 |
| Average True Range (ATR) | 0.24 | 0.08 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 27.91 | 49.21 |
Price Performance
Historical Comparison PODC
IOBT
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.